Marvel's Avengers is one of the more exciting new games coming to Stadia next month, and it'll come with early access for those that want to dive into things before everyone else.
In a blog post from earlier this week, Square Enix confirmed plenty of details about the game in regards to access around day one of launch. In this post it did confirm that Stadia players would have the opportunity to gain early access to the game.
Marvel's Avengers recently went though multiple closed and open betas. First on console, then on PC. Beginning with those who had pre-ordered before moving on to everyone in the weeks that followed. Stadia unfortunately did not have its own closed or open betas. So playing before the official launch on September 4 was looking less likely.
Early access for Marvel's Avengers on Stadia begins September 1
Stadia will get access to the game before the official launch. And one main difference between Stadia and other platforms which have early access it the lack of a requirement to buy the game in a pre-order.
Stadia doesn't really have pre-orders. So if you're eager to play and test things out, you can do so on September 1. You do still have to buy the game of course, it'll just be in an early access state that few days before launch.
This gives anyone who wants it, 72 hours of playtime before anyone else. Servers for the game are slated to open up at 9AM PST on September 1, which is next Tuesday. You may want to be prepared with the day off if you want to maximize that early play time.
Stadia players will get pre-order perks
Though Stadia won't have pre-orders, Stadia players can still get pre-order perks.
Going back to that early access period which starts three days before the official launch, if you want the pre-order perks, this is when you purchase the game. It's a limited time window. As you'll have just three days to buy Marvel's Avengers if you want the free in-game loot.
The pre-order perks include legacy outfits for the launch characters including Thor, Iron Man, The Hulk, Captain America, Black Widow, and Ms. Marvel.
Stadia users will also get special nameplates and the Obsidian Outfit Pack. If you didn't get a chance to play the beta, you unfortunately missed out. But you can still get a little bit of early play time starting next week.
После долгих месяцев карантина, Иванский продолжает расследование исчезновения (или даже похищения) двух туристок. Поиск в открытых источниках приносит неожиданные плоды, и Иванский отправляется на другой конец острова в поисках улик.
Majesco (MJCO) - Get Report, a global provider of cloud insurance platform software, today announced it went live with the latest version of Salesforce Sales Cloud.
Majesco is using Sales Cloud to revamp its client relationship management system. Sales Cloud will help to standardize sales processes, reduce manual efforts throughout the sales cycle while providing pipeline and forecast visibility to sales, marketing, partner, delivery and finance leaders across the organization. Sales Cloud is integrated with Salesforce Pardot, the B2B marketing automation tool that aligns to the sales process that is used by Majesco to capture, nurture, engage and convert leads to opportunities through marketing initiatives. This redeployment is another fundamental change to Majesco's systems and processes that furthers its digital transformation journey.
"We're thrilled to have taken this next step as we work to reshape the future of insurance", says Jim Miller, Chief Revenue Officer at Majesco. "This upgrade to the latest Sales Cloud technology directly aligns to our business model, supports our recent NetSuite implementation, and will be our single source of truth for all sales related data. We are committed to providing our customers with the best user experience possible and believe this revamped system will allow us to better understand and serve our customers."
Sales Cloud is a unified module for all types of revenue-based business orders. It provides defined reports for all levels including management, business units, sales leadership and sales performance and enables the organization to track history of opportunities, communications, tasks, targets and reports.
"Majesco is committed to helping insurers transform with cloud insurance software that modernizes, innovates and propels them to the future of their business", says Andrew Bearese, VP of Commercial Sales at Salesforce. "We are thrilled to have helped Majesco further their own digital transformation as it continues to deliver and build strong relationships with its customers."
About Majesco
Majesco (MJCO) - Get Report provides technology, expertise, and leadership that helps insurers modernize, innovate and connect to build the future of their business - and the future of insurance - at speed and scale. Our platforms connect people and businesses to insurance in ways that are innovative, hyper-relevant, compelling and personal. Over 200 insurance companies worldwide in P&C, L&A and Group Benefits are transforming their businesses by modernizing, optimizing or creating new business models with Majesco. Our market-leading solutions include CloudInsurer® P&C Core Suite (Policy, Billing, Claims); CloudInsurer® LifePlus Solutions (AdminPlus, AdvicePlus, IllustratePlus, DistributionPlus); CloudInsurer® L&A and Group Core Suite (Policy, Billing, Claims); Digital1st® Insurance with Digital1st® Engagement, Digital1st® EcoExchange and Digital1st® Platform - a cloud-native, microservices and open API platform; Distribution Management, Data and Analytics and an Enterprise Data Warehouse. For more details on Majesco, please visit www.majesco.com.
Cautionary Language Concerning Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act. These forward-looking statements are made on the basis of the current beliefs, expectations and assumptions of management, are not guarantees of performance and are subject to significant risks and uncertainty. These forward-looking statements should, therefore, be considered in light of various important factors, including those set forth in Majesco's reports that it files from time to time with the Securities and Exchange Commission and which you should review, including those statements under "Item 1A - Risk Factors" in Majesco's Annual Report on Form 10-K, as amended by its Quarterly Reports on Form 10-Q.
Important factors that could cause actual results to differ materially from those described in forward-looking statements contained in this press release include, but are not limited to: the adverse impact on economies around the world and our customers of the current COVID-19 pandemic; our ability to achieve increased market penetration for our product and service offerings and obtain new customers; our ability to raise future capital as needed; the growth prospects of the property & casualty and life & annuity insurance industry; the strength and potential of our technology platform and our ability to innovate and anticipate future customer needs; our ability to compete successfully against other providers and products; data privacy and cyber security risks; technological disruptions; our ability to successfully integrate our acquisitions and identify new acquisitions; the risk of loss of customers or strategic relationships; the success of our research and development investments; changes in economic conditions, political conditions and trade protection measures; regulatory and tax law changes; immigration risks; our ability to obtain, use or successfully integrate third-party licensed technology; key personnel risks; and litigation risks.
These forward-looking statements should not be relied upon as predictions of future events and Majesco cannot assure you that the events or circumstances discussed or reflected in these statements will be achieved or will occur. If such forward-looking statements prove to be inaccurate, the inaccuracy may be material. You should not regard these statements as a representation or warranty by Majesco or any other person that we will achieve our objectives and plans in any specified timeframe, or at all. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this presentation. Majesco disclaims any obligation to publicly update or release any revisions to these forward-looking statements, whether as a result of new information, future events or otherwise, after the date of this press release or to reflect the occurrence of unanticipated events, except as required by law.
MENLO PARK, Calif., Aug. 25, 2020 (GLOBE NEWSWIRE) -- CohBar, Inc. (CWBR) - Get Report (the "Company"), a clinical stage biotechnology company developing mitochondria based therapeutics to treat chronic diseases and extend healthy lifespan, today announced a proposed underwritten public offering of units consisting of one share of the Company's common stock and one warrant to purchase 0.75 of a share of common stock. Each warrant will be exercisable for five years from the closing date of the offering. All of the securities to be sold in the offering are being offered by the Company. In addition, the Company expects to grant the underwriters a 30-day option to purchase up to an additional 15% of the aggregate number of shares of common stock and/or 15% of the aggregate number of warrants offered. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.
Roth Capital Partners is acting as sole book-running manager for the offering and Brookline Capital Markets, a division of Arcadia Securities, LLC, and WBB Securities are acting as co-managers.
CohBar intends to use the net proceeds from the offering, together with its existing cash resources, for general corporate purposes, which may include funding preclinical and clinical development of its peptides, increasing working capital, operating expenses and capital expenditures.
The securities will be issued pursuant to an effective shelf registration statement filed with the Securities and Exchange Commission (SEC) on November 22, 2017. A preliminary prospectus supplement and accompanying prospectus relating to the offering will be filed with the SEC and will be available on the SEC's website at www.sec.gov . When available, copies of the prospectus supplement, together with the accompanying prospectus, can be obtained at the SEC's website at www.sec.gov or from Roth Capital Partners, 888 San Clemente, Newport Beach, CA 92660, Attn: Prospectus Department, telephone: 800-678-9147.
This press release does not and shall not constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or other jurisdiction. Any offer, if at all, will be made only by means of a prospectus, including a prospectus supplement, forming a part of the effective registration statement.
About CohBar
CohBar (CWBR) - Get Report is a clinical stage biotechnology company focused on the research and development of mitochondria based therapeutics, an emerging class of drugs for the treatment of chronic and age-related diseases. Mitochondria based therapeutics originate from the discovery by CohBar's founders of a novel group of naturally occurring peptide sequences within the mitochondrial genome, some of which have been shown to have the potential to regulate key processes in multiple systems and organs in the body. To date, the company has discovered more than 100 mitochondrial derived peptides and generated over 1,000 analogs. CohBar's efforts focus on the development of these peptides into therapeutics that offer the potential to address a broad range of diseases because of the underlying impact of mitochondrial dysfunction. The company's lead compound, CB4211, is in the Phase 1b stage of a Phase 1a/1b clinical trial for NASH and obesity. In addition, CohBar currently has four preclinical programs: CB5138 Analogs for fibrotic diseases, CB5064 Analogs for COVID-19 associated ARDS and type 2 diabetes, MBT5 Analogs for CXCR4-related cancer and orphan diseases, and MBT3 Analogs for cancer immunotherapy.
For additional company information, please visit www.cohbar.com .
Forward-Looking Statements
Certain of the statements made in this press release are forward looking, such as those, among others, relating to CohBar's expectations regarding the completion, timing and size of the proposed offering. Actual results or developments may differ materially from those projected or implied in these forward-looking statements. Factors that may cause such a difference include, without limitation, risks and uncertainties related to whether or not CohBar will be able to raise capital through the sale of its securities, the final terms of the proposed offering, market and other conditions, and the satisfaction of customary closing conditions related to the proposed public offering. There can be no assurance that CohBar will be able to complete the proposed public offering on the anticipated terms, or at all. You should not place undue reliance on these forward-looking statements, which apply only as of the date of this press release. Additional risks and uncertainties relating to the proposed public offering, CohBar and its business can be found under the heading "Risk Factors" in CohBar's Quarterly Report on Form 10-Q for the quarter ended June 30, 2020, and other filings with the SEC, and in the preliminary prospectus supplement related to the proposed public offering to be filed with the SEC on or about the date hereof. Except as otherwise required by law, CohBar does not undertake any obligation to update forward-looking statements and expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in its expectations with regard thereto or any change in events, conditions or circumstances on which any such statements are based.
Contacts: Jordyn Tarazi Director of Investor Relations CohBar, Inc. (650) 445-4441 jordyn.tarazi@cohbar.com
This is a change monitoring for https://feed.informer.com/widgets/CZWG3K6BOL.html delivered by deltaFeed
» Forma-odezhda.ru (@formaodezhdaru) - Post … 25/08/20 19:44 from forma-odezhda.ru - for full MediaForma-odezhda.ru03 августа 2020 04:07Forma-Odezhda.ru (Twitter) все электронные книги (fb2, fb3, epub, mobi, pdf, html, pdb, lit, doc, rtf, txt) аудиокнигиEen fantasy vol actie, die ongetwijfeld fans van Morgan Rice's voorgaande novels zal bekoren, evenals fans van werken zoals THE INHERITANCE CYCLE van… ... formaodezhda.wordpress.com/2020/08/03/287…Forma-Odezhda.ru (Twitter)Читать полностью…
Классификация
-
Классификация маркировка средств индивидуальной защиты по защитным
свойствам принята в соответствии с ГОСТ 12.4.103-83 ССБТ. Одежда
специальная защитная. С...
Композитный
-
Композитный подносок - это защитный элемент в рабочей обуви, предохраняющий
ногу от удара силой в 200 Дж. Подноски из композитных материалов отличаются
неб...
together: “Image” plus 49 more
-
together: “Image” plus 49 more [image: Link to together]
------------------------------
- Image
- Nubia анонсировала клавиатуру и мышь Red Magic д...
Gmail - enacademic.com
-
Gmail is a free, advertising-supported email service provided by Google.
[1] Users may access Gmail as secure webmail, [2] as well via POP3 or IMAP
protoco...
Gmail - enacademic.com
-
Gmail is a free, advertising-supported email service provided by Google.
[1] Users may access Gmail as secure webmail, [2] as well via POP3 or IMAP
protoco...
Liste der Unterrichtsmethoden
-
Schlagen Sie auch in anderen Wörterbüchern nach: Liste Frankfurter
Straßennamen/K — Inhaltsverzeichnis 1 Ka 2 Ke 3 Ki 4 Kn 5 Kr 6 Ku 7 Quellen
// … Deutsch...
Liste der Unterrichtsmethoden
-
Schlagen Sie auch in anderen Wörterbüchern nach: Liste Frankfurter
Straßennamen/K — Inhaltsverzeichnis 1 Ka 2 Ke 3 Ki 4 Kn 5 Kr 6 Ku 7 Quellen
// … Deutsch...
Список латинских писателей раннего Средневековья
-
В статье представлен список латиноязычных авторов раннего Средневековья (а
также в ряде случаев их основных произведений) — от падения Западной
Римской имп...
Список латинских писателей раннего Средневековья
-
В статье представлен список латиноязычных авторов раннего Средневековья (а
также в ряде случаев их основных произведений) — от падения Западной
Римской имп...
quechuan_spanish.esacademic.com › Situma
-
s. Etnohist. Reino preinkásico que habitó las provincias de Azuay, Cañar,
parte de Loja y Guayas en Ecuador. A esta nación se dio por llamar Kañari,
...
convocar
-
(Del lat. convocare, llamar a junta.) verbo transitivo 1 Llamar o citar a
una o más personas para que acudan a un lugar: la dirección ha convocado a
los je...
convocar
-
(Del lat. convocare, llamar a junta.) verbo transitivo 1 Llamar o citar a
una o más personas para que acudan a un lugar: la dirección ha convocado a
los je...
esacademic.com - host.io
-
esacademic.com (hosted on amazon.com) details, including IP, backlinks,
redirect information, and reverse IP shared hosting data
Перевод:
-
"Non si sentiva la stessa Ida di prima, ma un'avventuriera dalla doppia
vita" (E. Morante) — "У неё было ощущение, что она не прежняя Ида, а
авантюристка, ...
Берет - головной убор Израильской Армии
-
Берет это основной головной убор в Армии Обороны Израиля. Одной из
особенностей ЦАХАЛа, которая сразу бросается в глаза стороннему наблюдателю
является пог...
PrimaLoft - forma-odezhda.ru
-
PrimaLoft ®One поглощает в 3 раза меньше воды, на 14% теплее в сухом
состоянии и на 24% теплее в мокром, по сравнению с другими материалами.
Утеплитель Pri...
Берет - головной убор Израильской Армии
-
Берет это основной головной убор в Армии Обороны Израиля. Одной из
особенностей ЦАХАЛа, которая сразу бросается в глаза стороннему наблюдателю
является пог...
https://zzap.run/formaodezhdaru/327234
-
Forma-odezhda.ru (VK)
В состав Федеральной службы войск национальной гвардии Российской Федерации
включены:
*-- Delivered by Feed43 service*
Telegram: Contact @enacademic
-
New post in Enacademic Analogindex: Article: Article: English: Article:
Detected change on https://clck.... (forma-odezhda.ru)
https://ift.tt/2PGJxo7
*T...
Telegram: Contact @enacademic
-
New post in Enacademic Analogindex: @formaodezhdaru posted a photo
https://ift.tt/39udI90 https://ift.tt/2PG3awy
*Tags:* telegram
Telegram: Contact @enacademic
-
New post in Enacademic Analogindex: https://ift.tt/39KQbkr https://www...
https://ift.tt/3sEj88P https://ift.tt/39KQbkr https://ift.tt/39KQbkr
https://if...
Darken ² - academic2.ru
-
4 juil. 2020 - «Darken» в толковых словарях и энциклопедиях: darken. verb
(I, T) 1 to become dark, or make something dark: the skies darkened | The
sun had...
Darken ² - academic2.ru
-
4 juil. 2020 - «Darken» в толковых словарях и энциклопедиях: darken. verb
(I, T) 1 to become dark, or make something dark: the skies darkened | The
sun had...
Производитель Eunyul - academic2.ru
-
В наборе вы найдете 5 разных тканевых масок Eunyul для комплексного ухода.
1) Маска с экстрактом алоэ интенсивно увлажняет и смягчает кожу, ...
[[ This is ...
Found this on Pinterest
-
This Pin was discovered by Enacademic Analogindex. Discover (and save!)
your own Pins on Pinterest. via www.pinterest.com/pin/84702…
Found this on Pinterest
-
This Pin was discovered by Enacademic Analogindex. Discover (and save!)
your own Pins on Pinterest. via www.pinterest.com/pin/84702…
RSSMix.com Mix ID 11528279
-
RSSMix.com Mix ID 11528279RSSMix.com Mix ID 11528279Мини-кукла Emco, 1098,
коричневый, бирюзовый Gelato Surprise...Каталка детская Sport car
(резиновые кол...
RSSMix.com Mix ID 11528279
-
RSSMix.com Mix ID 11528279RSSMix.com Mix ID 11528279Мини-кукла Emco, 1098,
коричневый, бирюзовый Gelato Surprise...Каталка детская Sport car
(резиновые кол...
Униформа армейских гусар 1801-1825 годов
-
via together Униформа гусар Российской Императорской армии 1801-1825 годов
В двух предыдущих статьях мы рассказали об униформе русских армейских
гусарски...
Twitter
-
Товары из категории советник юстиции …: https://t.co/gD6hlqSpDg…
http://twitter.com/formaodezhdaru/status/1255650085981106180 Товары из
категории советни...
ризничий ² – Русский орфографический словарь
-
1 oct. 2019 – Смотреть что такое "ризничий" в других словарях: РИЗНИЧИЙ —
РИЗНИЧИЙ, ризничего, муж. (церк.). Заведующий ризницей. Толковый словарь …
from A...
"Форма одежды" - все для службы и туризма
-
Звоните с 9:00-20:00 пн-пт E-mail: info@forma-odezhda.ru. В корзине нет
товаров. Ваша корзина пуста!
🔗 Товары из категории армия польши Купить - …
"Форма одежды" - все для службы и туризма
-
Звоните с 9:00-20:00 пн-пт E-mail: info@forma-odezhda.ru. В корзине нет
товаров. Ваша корзина пуста!
🔗 Товары из категории армия польши Купить - …
Forma-odezhda.ru
-
Звоните с 9:00-20:00 пн-пт E-mail: info@forma-odezhda.ru. В корзине нет
товаров. Ваша корзина пуста!
🔗 Товары из категории армия египта Купить - …
Forma-odezhda.ru
-
Звоните с 9:00-20:00 пн-пт E-mail: info@forma-odezhda.ru. В корзине нет
товаров. Ваша корзина пуста!
🔗 Товары из категории армия египта Купить - …
Комментариев нет:
Отправить комментарий